Peter Buckle

Peter Buckle

Auto-generated profile, based on publicly available information

Peter Buckle

Department of Surgery and Cancer, Imperial College, London, UK

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 April 2022 in Applied Ergonomics
Verified
Journal Article
Open access
ATArkeliana Tase
Arkeliana Tase
BVBhamini Vadhwana
Bhamini Vadhwana
PBPeter Buckle
Peter Buckle
GHGeorge B. Hanna
George B. Hanna
Home care medical devices are the fastest-growing segment of the medical device industry with associated safety and usability challenges. Human factor studies in the home environment present many difficulties resulting in limited knowledge of device use in this setting. This systematic review aims to identify usability challenges reported directly by end-users in the home environment. A systematic review of the literature was conducted concentrating on studies involving end user reporting. Reported challenges were grouped into a) device-user, b) device use environment and c) device-user interface challenges. 3471 studies were screened and 202 underwent full-text review. Only twelve studies had direct involvement of end users. Multiple challenges were identified, with device-user interface problems being the most common. No effective, standardised method was found to collect patient/user feedback on usability challenges in the post-market stage, leading to a knowledge gap. This study brought together multiple usability challenges reported by individual studies. Involvement of medical device end-users in usability studies is essential and their experiences must be effectively utilised in device design.


Verified
Journal Article
Open access
PDF file
MMMassimo Micocci
Massimo Micocci
SBSimone Borsci
Simone Borsci
VTViral Thakerar
Viral Thakerar
SWSimon Walne
Simon Walne
YMYasmine Manshadi
Yasmine Manshadi
GHGeorge B. Hanna
George B. Hanna
Artificial Intelligence (AI) systems could improve system efficiency by supporting clinicians in making appropriate referrals. However, they are imperfect by nature and misdiagnoses, if not correctly identified, can have consequences for patient care. In this paper, findings from an online survey are presented to understand the aptitude of GPs (n = 50) in appropriately trusting or not trusting the output of a fictitious AI-based decision support tool when assessing skin lesions, and to identify which individual characteristics could make GPs less prone to adhere to erroneous diagnostics results. The findings suggest that, when the AI was correct, the GPs’ ability to correctly diagnose a skin lesion significantly improved after receiving correct AI information, from 73.6% to 86.8% (X2 (1, N = 50) = 21.787, p < 0.001), with significant effects for both the benign (X2 (1, N = 50) = 21, p < 0.001) and malignant cases (X2 (1, N = 50) = 4.654, p = 0.031). However, when the AI provided erroneous information, only 10% of the GPs were able to correctly disagree with the indication of the AI in terms of diagnosis (d-AIW M: 0.12, SD: 0.37), and only 14% of participants were able to correctly decide the management plan despite the AI insights (d-AIW M:0.12, SD: 0.32). The analysis of the difference between groups in terms of individual characteristics suggested that GPs with domain knowledge in dermatology were better at rejecting the wrong insights from AI.

16 July 2021 in Age and Ageing
Verified
Journal Article
Open access
PDF file
JTJohn S P Tulloch
John S P Tulloch
MMMassimo Micocci
Massimo Micocci
PBPeter Buckle
Peter Buckle
KLKaren Lawrenson
Karen Lawrenson
PKPatrick Kierkegaard
Patrick Kierkegaard
PPPaula Parvulescu
Paula Parvulescu
Introduction: Care homes have been severely affected by the SARS-CoV-2 pandemic. Rapid antigen testing could identify most SARS-CoV-2 infected staff and visitors before they enter homes. We explored implementation of staff and visitor testing protocols using lateral flow devices (LFDs). Methods: An evaluation of a SARS-CoV-2 LFD-based testing protocol in 11 care homes in Liverpool, UK, including staff and visitor testing, plus a qualitative exploratory study in nine of these homes. The proportion of pilot homes with outbreaks, and outbreak size, were compared to non-pilot homes in Liverpool. Adherence to testing protocols was evaluated. Fifteen staff were interviewed, and transcript data were thematically coded using an iterative analysis to identify and categorize factors influencing testing implementation. Results: In total, 1,638 LFD rapid tests were performed on 407 staff. Protocol adherence was poor with 8.6% of staff achieving >75% protocol adherence, and 25.3% achieving $\ge$50%. Six care homes had outbreaks during the study. Compared to non-pilot care homes, there was no evidence of significant difference in the proportion of homes with outbreaks, or the size of outbreaks. Qualitative data showed difficulty implementing testing strategies due to excessive work burden. Factors influencing adherence related to test integration and procedural factors, socio-economic factors, cognitive overload and the emotional value of testing. Conclusion: Implementation of staff and visitor care home LFD testing protocols was poorly adhered to and consequently did not reduce the number or scale of COVID-19 outbreaks. More focus is needed on the contextual and behavioural factors that influence protocol adherence.

22 January 2021 in Age and Ageing
Verified
Journal Article
Open access
PDF file
MMMassimo Micocci
Massimo Micocci
OTon behalf of the CONDOR study team
on behalf of the CONDOR study team
AGAdam Lee Gordon
Adam Lee Gordon
JAJoy Allen
Joy Allen
Timothy HicksTimothy Hicks
Timothy Hicks
PBPeter Buckle
Peter Buckle
Introduction: Care home residents are at high risk of dying from COVID-19. Regular testing, producing rapid and reliable results is important in this population because infections spread quickly, and presentations are often atypical or asymptomatic. This study evaluated current testing pathways in care homes to explore the role of point-of-care tests (POCTs). Methods: Ten staff from eight care homes, purposively sampled to reflect care organisational attributes that influence outbreak severity, underwent a semi-structured remote videoconference interview. Transcripts were analysed using process mapping tools and framework analysis focussing on perceptions about, gaps within, and needs arising from, current pathways. Results: Four main steps were identified in testing: infection prevention, preparatory steps, swabbing procedure, and management of residents. Infection prevention was particularly challenging for mobile residents with cognitive impairment. Swabbing and preparatory steps were resource-intensive, requiring additional staff resource. Swabbing required flexibility and staff who were familiar to the resident. Frequent approaches to residents were needed to ensure they would participate at a suitable time. After-test management varied between sites. Several homes reported deviating from government guidance to take more cautious approaches, which they perceived to be more robust. Conclusion: Swab-based testing is organisationally complex and resource-intensive in care homes. It needs to be flexible to meet the needs of residents and provide care homes with rapid information to support care decisions. POCT could help address gaps but the complexity of the setting means that each technology must be evaluated in context before widespread adoption in care homes.

22 August 2025 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
SBShayan Bahadori
Shayan Bahadori
PBPeter Buckle
Peter Buckle
TATayana Soukup Ascensao
Tayana Soukup Ascensao
SGSaira Ghafur
Saira Ghafur
PKPatrick Kierkegaard
Patrick Kierkegaard
The rapid advancement of artificial intelligence (AI)–driven diagnostics and wearable health technologies is transforming health care delivery by enabling real-time health monitoring and early disease detection. These innovations are catalyzing a shift toward personalized medicine, with interventions tailored to individual patient profiles with unprecedented precision. This paper examines the current National Institute for Health and Care Excellence (NICE) evidence standards framework (ESF) for digital health technologies (DHTs) and evaluates the challenges associated with integrating DHTs into existing health and care systems. A comprehensive review of the NICE ESF guidelines was conducted, alongside an evaluation of their applicability to emerging AI and wearable technologies. Key limitations and barriers were identified, with particular focus on the framework’s responsiveness to technologies that evolve through machine learning and real-world data integration. Our findings indicate that while the NICE ESF provides a structured approach for evaluating DHTs, it lacks the adaptability required for rapidly evolving innovations. The framework does not sufficiently incorporate real-world evidence or support continuous learning models, which are critical for the safe and effective deployment of AI-based diagnostics and wearables. To remain effective and relevant, the NICE ESF should transition to a dynamic, adaptive model co-designed with industry stakeholders. By embedding real-world evidence-based strategies and promoting transparency, efficiency, and collaborative innovation, the updated framework would better facilitate the integration of AI-driven diagnostics and wearables into health care systems, ultimately enhancing patient outcomes and optimizing health care delivery.